A compound heterozygous ADAMTS13 mutation causes congenital thrombotic thrombocytopenic purpura: a case report

Congenital thrombotic thrombocytopenic purpura (cTTP) is a thrombotic microangiopathy (TMA) characterized by severe hereditary ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin type 1 motifs 13) deficiency caused by ADAMTS13 mutations. This rare autosomal recessive genetic disorder i...

Full description

Saved in:
Bibliographic Details
Main Authors: Yezi Huang, Lixia Zhou, Yuan Song, Wanting Zou, Aiping Tang, Si Tao, Duozhuang Tang
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2024.1525062/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841555200195690496
author Yezi Huang
Lixia Zhou
Yuan Song
Wanting Zou
Aiping Tang
Si Tao
Duozhuang Tang
author_facet Yezi Huang
Lixia Zhou
Yuan Song
Wanting Zou
Aiping Tang
Si Tao
Duozhuang Tang
author_sort Yezi Huang
collection DOAJ
description Congenital thrombotic thrombocytopenic purpura (cTTP) is a thrombotic microangiopathy (TMA) characterized by severe hereditary ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin type 1 motifs 13) deficiency caused by ADAMTS13 mutations. This rare autosomal recessive genetic disorder is often misdiagnosed as immune thrombocytopenia (ITP) or hemolytic uremic syndrome (HUS). Here, we report a 21-year-old male cTTP patient with a compound heterozygous ADAMTS13 mutation. The patient was admitted for acute thrombocytopenia, with a 5-year history of chronic thrombocytopenia and 1 month of renal dysfunction. Initially diagnosed with ITP, he was treated with immunosuppressive therapy, including glucocorticoids and intravenous immunoglobulin, which provided temporary relief but failed to prevent recurrent thrombocytopenia. Ultimately, cTTP was confirmed by the low ADAMTS13 0% activity and two heterozygous variants (c.1335del and c.1045C > T) in the ADAMTS13 gene, and the patient received prophylactic fresh-frozen plasma (FFP) infusions every 2–3 weeks regularly. Interestingly, the patient also exhibited elevated sC5b-9 levels during the acute phase, necessitating differentiation from HUS. This report highlights a cTTP caused by a compound heterozygous ADAMTS13 mutation, although its pathogenesis requires further investigation. Given the atypical clinical manifestations of cTTP, it is necessary to conduct ADAMTS13 activity and even genetic testing in patients with recurrent thrombocytopenia and end-organ damage.
format Article
id doaj-art-e2da4090237e4df8b86ac669bac800d5
institution Kabale University
issn 2296-858X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj-art-e2da4090237e4df8b86ac669bac800d52025-01-08T06:11:47ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2025-01-011110.3389/fmed.2024.15250621525062A compound heterozygous ADAMTS13 mutation causes congenital thrombotic thrombocytopenic purpura: a case reportYezi Huang0Lixia Zhou1Yuan Song2Wanting Zou3Aiping Tang4Si Tao5Duozhuang Tang6Department of Hematology, The Second Affiliated Hospital of Nanchang University, Nanchang, ChinaDepartment of Hematology, The Second Affiliated Hospital of Nanchang University, Nanchang, ChinaDepartment of Hematology, The Second Affiliated Hospital of Nanchang University, Nanchang, ChinaDepartment of Hematology, The Second Affiliated Hospital of Nanchang University, Nanchang, ChinaDepartment of Hematology, The Second Affiliated Hospital of Nanchang University, Nanchang, ChinaDepartment of Oncology, The Second Affiliated Hospital of Nanchang University, Nanchang, ChinaDepartment of Hematology, The Second Affiliated Hospital of Nanchang University, Nanchang, ChinaCongenital thrombotic thrombocytopenic purpura (cTTP) is a thrombotic microangiopathy (TMA) characterized by severe hereditary ADAMTS13 (a disintegrin and metalloproteinase with thrombospondin type 1 motifs 13) deficiency caused by ADAMTS13 mutations. This rare autosomal recessive genetic disorder is often misdiagnosed as immune thrombocytopenia (ITP) or hemolytic uremic syndrome (HUS). Here, we report a 21-year-old male cTTP patient with a compound heterozygous ADAMTS13 mutation. The patient was admitted for acute thrombocytopenia, with a 5-year history of chronic thrombocytopenia and 1 month of renal dysfunction. Initially diagnosed with ITP, he was treated with immunosuppressive therapy, including glucocorticoids and intravenous immunoglobulin, which provided temporary relief but failed to prevent recurrent thrombocytopenia. Ultimately, cTTP was confirmed by the low ADAMTS13 0% activity and two heterozygous variants (c.1335del and c.1045C > T) in the ADAMTS13 gene, and the patient received prophylactic fresh-frozen plasma (FFP) infusions every 2–3 weeks regularly. Interestingly, the patient also exhibited elevated sC5b-9 levels during the acute phase, necessitating differentiation from HUS. This report highlights a cTTP caused by a compound heterozygous ADAMTS13 mutation, although its pathogenesis requires further investigation. Given the atypical clinical manifestations of cTTP, it is necessary to conduct ADAMTS13 activity and even genetic testing in patients with recurrent thrombocytopenia and end-organ damage.https://www.frontiersin.org/articles/10.3389/fmed.2024.1525062/fullcongenital thrombotic thrombocytopenic purpuraADAMTS13thrombotic microangiopathysC5b-9case report
spellingShingle Yezi Huang
Lixia Zhou
Yuan Song
Wanting Zou
Aiping Tang
Si Tao
Duozhuang Tang
A compound heterozygous ADAMTS13 mutation causes congenital thrombotic thrombocytopenic purpura: a case report
Frontiers in Medicine
congenital thrombotic thrombocytopenic purpura
ADAMTS13
thrombotic microangiopathy
sC5b-9
case report
title A compound heterozygous ADAMTS13 mutation causes congenital thrombotic thrombocytopenic purpura: a case report
title_full A compound heterozygous ADAMTS13 mutation causes congenital thrombotic thrombocytopenic purpura: a case report
title_fullStr A compound heterozygous ADAMTS13 mutation causes congenital thrombotic thrombocytopenic purpura: a case report
title_full_unstemmed A compound heterozygous ADAMTS13 mutation causes congenital thrombotic thrombocytopenic purpura: a case report
title_short A compound heterozygous ADAMTS13 mutation causes congenital thrombotic thrombocytopenic purpura: a case report
title_sort compound heterozygous adamts13 mutation causes congenital thrombotic thrombocytopenic purpura a case report
topic congenital thrombotic thrombocytopenic purpura
ADAMTS13
thrombotic microangiopathy
sC5b-9
case report
url https://www.frontiersin.org/articles/10.3389/fmed.2024.1525062/full
work_keys_str_mv AT yezihuang acompoundheterozygousadamts13mutationcausescongenitalthromboticthrombocytopenicpurpuraacasereport
AT lixiazhou acompoundheterozygousadamts13mutationcausescongenitalthromboticthrombocytopenicpurpuraacasereport
AT yuansong acompoundheterozygousadamts13mutationcausescongenitalthromboticthrombocytopenicpurpuraacasereport
AT wantingzou acompoundheterozygousadamts13mutationcausescongenitalthromboticthrombocytopenicpurpuraacasereport
AT aipingtang acompoundheterozygousadamts13mutationcausescongenitalthromboticthrombocytopenicpurpuraacasereport
AT sitao acompoundheterozygousadamts13mutationcausescongenitalthromboticthrombocytopenicpurpuraacasereport
AT duozhuangtang acompoundheterozygousadamts13mutationcausescongenitalthromboticthrombocytopenicpurpuraacasereport
AT yezihuang compoundheterozygousadamts13mutationcausescongenitalthromboticthrombocytopenicpurpuraacasereport
AT lixiazhou compoundheterozygousadamts13mutationcausescongenitalthromboticthrombocytopenicpurpuraacasereport
AT yuansong compoundheterozygousadamts13mutationcausescongenitalthromboticthrombocytopenicpurpuraacasereport
AT wantingzou compoundheterozygousadamts13mutationcausescongenitalthromboticthrombocytopenicpurpuraacasereport
AT aipingtang compoundheterozygousadamts13mutationcausescongenitalthromboticthrombocytopenicpurpuraacasereport
AT sitao compoundheterozygousadamts13mutationcausescongenitalthromboticthrombocytopenicpurpuraacasereport
AT duozhuangtang compoundheterozygousadamts13mutationcausescongenitalthromboticthrombocytopenicpurpuraacasereport